Search for: "Myriad Genetics" Results 181 - 200 of 856
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Aug 2013, 6:23 am by Joe Mullin
Duncan Hull / flickr For many years, all testing of the BRCA1 and BRCA2 genes in the US was under control of one company: Myriad Genetics of Utah. [read post]
13 Jun 2012, 11:40 am by Patent Docs
Noonan -- The Federal Circuit today denied Defendant Myriad Genetics' motion, styled as "Appellant's Suggestion of Mootness, or, in the Alternative, Motion to Remand," seeking to reopen the question of whether Dr. [read post]
14 Jun 2013, 2:38 pm by Dennis Crouch
Thus, although Myriad disclosed the BRCA1/BRCA2 gene sequences in their patent applications, the company holds a vast amount of information (such as the genetic code of all of its customers) as trade secrets. [read post]
13 Jun 2013, 8:14 am by HealthLawProf Hodnicki
The case concerned patents held by Myriad Genetics, a Utah company, on genes that correlate with increased risk of hereditary... [read post]
11 Apr 2013, 8:32 am by Rahul Bhagnari, ACLU
In 2008 and again in 2009 we testified to the Secretary's Advisory Committee on Genetics Health and Society, expressing our concerns with direct-to-consumer marketing of genetic tests, and specifically Myriad's marketing practices, which we feel encourages BRCA testing without first receiving genetic counseling from qualified experts trained in cancer genetics. [read post]
2 Mar 2010, 4:06 am by Lawrence B. Ebert
The Washington Post has an article on the Myriad patent case, titled: Lawsuit attacks patent giving company control over genetic test for cancer risk.IPBiz found interesting the emphasis on the following in a quote of Richard Marsh, executive VP of Myriad:"It is an expensive test; affordability is a concern. [read post]
1 Nov 2010, 9:59 pm by Patent Docs
By Donald Zuhn -- On October 22, Defendants-Appellants Myriad Genetics, Inc. and ten Directors of the University of Utah Research Foundation filed their brief in Association of Molecular Pathology v. [read post]
15 Apr 2013, 7:16 am by Rahul Bhagnari, ACLU
Myriad has a monopoly on BRCA genetic testing in the U.S. and therefore controls the type and price of testing. [read post]
6 Oct 2014, 9:00 pm by Dennis Crouch
University of Utah and Myriad Genetics are back at the Federal Circuit after losing a motion for preliminary injunction against the genetic testing company Ambry Genetics. [read post]
22 Aug 2010, 9:57 pm by Patent Docs
By Donald Zuhn -- In June, Myriad Genetics and ten Directors of the University of Utah Research Foundation filed a Notice of Appeal in Association for Molecular Pathology v. [read post]
7 Nov 2018, 2:59 pm by Patent Docs
Myriad Genetics, 689 F. 3d 1303 (2013), was that permitting Myriad and the University of Utah to have patent rights to isolate human DNA inhibited basic research. [read post]
5 Sep 2014, 9:38 am by Gene Quinn
Myriad Genetics, Inc., the Federal Court of Australia ruled that Myriad's claims to isolated DNA are patentable under the laws of Australia. [read post]
Myriad Genetics, Inc., that “a naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated. [read post]
24 Feb 2013, 6:31 pm by Rantanen
Myriad opinion for reconsideration in light of Mayo. [read post]
1 Nov 2010, 7:56 am by Lawrence B. Ebert
According to a study published last May in the journal Genomics, the patent should never have been granted, since it allowed the patent holder, a biotech company called Myriad Genetics, to establish a US monopoly on genetic testing for breast and ovarian cancer risk. [read post]
29 Aug 2013, 4:00 am by John Willinsky
I want to add my voice to those concerned with what might be cast as Myriad Genetics Inc.' [read post]
29 Mar 2014, 11:28 pm by Mark Summerfield
The US Patent and Trademark Office (USPTO) has concluded that recent decisions of the US Supreme Court relating to patents for genes and for diagnostic methods mean that mixtures of ‘naturally-occurring materials’ are not patent-eligible – at least, not unless one or more of the components has been ‘changed’ in some way from its natural state.The USPTO has published an extensive (93-slide) presentation used for examiner training [PDF, 972KB] on the Supreme Court’s… [read post]